Tradestie Institutional Equity Comparison Engine
BMRA vs TCMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus TCMD at 18.2x Forward P/E and 9.4% operating margin (+7.1% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
BMRA N/M vs TCMD 18.2x Fwd P/E
Growth & Margin Winner
TCMD
Op Margin -125.2% vs 9.4% ยท YoY -8.3% vs +7.1%
Momentum & Technical Winner
TCMD
1Y -45.6% vs +8.2% ยท 52W Pos 5% vs 34%
Options & Structure Winner
TCMD
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (15th %ile IV)
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap
$6.0M
1M Return
-26.49%
1Y Return
-45.6%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$26.36
-1.68% 1D
Market Cap
$601.1M
1M Return
+17.05%
1Y Return
+8.17%
Forward P/E
18.2x
Unified AI Score
25.0 / 100
SELL
Tech 50.0
Fund 27.0
Flow 66.0
Mom 21.4
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMRA -45.6%
TCMD +8.17%
Spread: +53.77 pp (TCMD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BMRA Revenue | TCMD Revenue | BMRA Op. Margin | TCMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $190M | -46.4% | 5.5% | TCMD |
| FY2020 | $10M | $190M | -41.0% | -1.9% | TCMD |
| FY2021 | $10M | $210M | -104.2% | -0.8% | TCMD |
| FY2022 | $20M | $250M | -24.0% | -5.2% | TCMD |
| FY2023 | $10M | $270M | -135.3% | 6.6% | TCMD |
| FY2024 | $10M | $290M | -117.6% | 7.6% | TCMD |
| FY2025 | $10M | $330M | -96.7% | 8.9% | TCMD |
| FY2026 | $0M | N/A | -119.5% | N/A | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMRA | TCMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.0M | $601.1M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | N/M | 26.1x | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | N/M | 18.2x | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | -8.3% | +7.1% | Higher Growth | TCMD |
| Operating Margin (TTM) Profitability | -125.2% | 9.4% | Higher Margin | TCMD |
| Net Profit Margin Profitability | -115.5% | 6.7% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | -113.8% | 11.0% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 5% ($1โ$3) | 34% ($21โ$38) | Stronger Trend | TCMD |
| Beta / 30D Volatility Risk Regime | 0.67ฮฒ ยท 62% Vol | 1.00ฮฒ ยท 53% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 25.0 / 100 (SELL) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMRA vs TCMD Buy Guide
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TCMD
CONSOLIDATION
94d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMRA nor TCMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.